Understanding GLP-1 Weight Loss Medications: Semaglutide vs. Tirzepatide
If you've been researching medical weight loss, you've likely come across two medications dominating the conversation: semaglutide and tirzepatide. Both are GLP-1 receptor agonists — a class of drugs that have revolutionized obesity treatment — but they work differently and produce different results.
Here's everything you need to know to make an informed decision with your provider.
What Is a GLP-1 Medication?
GLP-1 (glucagon-like peptide-1) receptor agonists mimic a natural gut hormone that:
- Suppresses appetite by signaling fullness to the brain
- Slows gastric emptying (food stays in your stomach longer)
- Improves insulin sensitivity and blood sugar regulation
- Reduces cravings for high-calorie foods
The result is consistent, significant weight loss — far beyond what most patients achieve with diet and exercise alone.
Semaglutide: Proven, Well-Tolerated, Widely Available
Semaglutide is the active molecule in Ozempic® (for diabetes) and Wegovy® (for weight loss). It's been studied in some of the largest weight loss trials in history.
Clinical results: In the STEP trials, semaglutide produced an average weight loss of 15–20% of body weight over 68 weeks — roughly 30–40 lbs for a 200-lb person.
How it's given: Weekly self-injection using a small pen. Dose starts low and titrates up over weeks to minimize side effects.
EdenRx pricing: Compound semaglutide starting at $299/month — up to 80% less than brand-name Wegovy®.
Best for: Patients new to GLP-1 therapy, those with moderate weight loss goals, and patients who want the most studied and well-tolerated option.
Tirzepatide: Dual-Action, Maximum Results
Tirzepatide is the active molecule in Mounjaro® (for diabetes) and Zepbound® (for weight loss). It's a dual GLP-1/GIP receptor agonist — meaning it activates two hormone pathways instead of one.
Clinical results: In the landmark SURMOUNT trials, tirzepatide produced average weight loss of up to 22.5% of body weight — the highest ever recorded for any weight loss medication. For a 220-lb person, that's nearly 50 lbs.
How it's given: Weekly self-injection. Also starts at a low dose and titrates up.
EdenRx pricing: Compound tirzepatide starting at $549/month.
Best for: Patients who want maximum weight loss results, those who haven't responded well to semaglutide, and patients with a higher starting weight.
Head-to-Head: Semaglutide vs. Tirzepatide
| Feature | Semaglutide | Tirzepatide | |---|---|---| | Mechanism | GLP-1 agonist | GLP-1 + GIP dual agonist | | Avg. weight loss | 15–20% | Up to 22.5% | | EdenRx price | From $299/mo | From $549/mo | | Brand-name equiv. | Ozempic® / Wegovy® | Mounjaro® / Zepbound® | | Best for | Beginners, proven results | Maximum weight loss |
Which Should You Choose?
The honest answer: it depends on your health profile, goals, and medical history — which is exactly why every EdenRx patient gets a real licensed provider review before any prescription is issued.
Generally:
- Start with semaglutide if you're new to GLP-1 therapy or want a more gradual approach
- Choose tirzepatide if you want maximum results and your provider determines you're a good candidate
Ready to Find Out Which Is Right for You?
EdenRx providers personally review every patient case and recommend the best GLP-1 medication based on your health history, goals, and medical profile. Get started with a free 5-minute assessment — no clinic visit required.
Treatment requires provider approval. Individual results vary. Compound medications are not FDA-approved under the same NDA as brand-name equivalents.
